Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,014 public trials 1,020 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Recruiting

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT07005154

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Sharp HealthCare - Sharp Memorial Hospital San Diego, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Associated Urological Specialists Chicago Ridge, Illinois, United States
View all 50 locations
View Trial Details
Recruiting

The TASTY-steering Study

NCT07258563

Conditions
Breast Diseases, Breast Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations
  • Amsterdam UMC Amsterdam, Netherlands
  • Rijnstate Ziekenhuis Arnhem, Netherlands
  • Van Weel-Bethesda Ziekenhuis Dirksland, Netherlands
  • Ziekenhuisvoorzieningen Gelderse Vallei Ede, Netherlands
View Trial Details
Recruiting

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

NCT05691465

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

NCT07570979

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Hirakata, Osaka, Japan
View Trial Details

Related conditions